Trials / Active Not Recruiting
Active Not RecruitingNCT04745754
The Engaging Primary Care in Cancer Survivorship (EPICS) Study
The EPICS (Engaging Primary Care in Cancer Survivorship) Study: A Trial of Novel Models of Care for Cancer Survivors
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 2,450 (estimated)
- Sponsor
- Kaiser Permanente · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
A quasi-experimental non-randomized pre/post with control group trial of two models of cancer survivorship care in early-stage colorectal and breast cancer survivors cared for in a community-based, integrated health care setting.
Detailed description
A quasi-experimental non-randomized pre/post with control group trial of two models of cancer survivorship care in early-stage colorectal and breast cancer survivors cared for in a community-based, integrated health care setting. The trial will test the efficacy of an embedded primary care provider (PCP) model (experimental condition) in which PCPs are embedded within an oncology practice and will care for low-risk survivors who will be transitioned at 6-36 months post-treatment for comprehensive survivorship care. We hypothesize that a) patients in the PCP model will have superior receipt of recommended care compared to usual care; b) patients in the PCP model will perceive significantly better care coordination, self-efficacy, and confidence in their PCP compared to usual care; and c) use of unplanned and non-recommended care will be less in the PCP model compared to usual care.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Embedded primary care in cancer survivorship model | Primacy care physicians will receive comprehensive training in cancer survivorship care for low-risk, early stage breast and colorectal patients. Training will include continuing medical education (CME) modules, webinars, and in-person discussion and clinical shadowing. |
Timeline
- Start date
- 2021-09-21
- Primary completion
- 2026-02-28
- Completion
- 2026-02-28
- First posted
- 2021-02-09
- Last updated
- 2025-12-12
Locations
13 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT04745754. Inclusion in this directory is not an endorsement.